ELTX · Elicio Therapeutics, Inc. · Debt
$2.05
-0.06 (-2.84%)
At close · Sep 11
Going-concern doubt
— flagged Aug 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“We are currently facing substantial doubt about our ability to continue as a going concern, given our cash position and cash runway.”View the 10-Q filed Aug 13, 2026
Market Cap
$53.88M
Shares
26.28M
Debt Profile
Annual debt figures are established from 10-K filings and updated by subsequent 10-Q and 8-K disclosures. Instrument balances are not summed into a company total unless the filing itself reports that total.
Debt data is being processed. Please check back later.
Key facts
CIK
1601485
CUSIP
28657F103
13F (30d)
19 filings
19 filers
Visit website
Investor relations